Cor Vasa 2009, 51(11-12):834

Nahradí nová antiagregancia clopidogrel?

MUDr. Pavel Jerie
Leymenstrasse 49, CH 4153 Reinach, BL 1, ©výcarsko

Published: November 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jerie P. Nahradí nová antiagregancia clopidogrel? Cor Vasa. 2009;51(11-12):834.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bhatt DL. Prasugrel in clinical practice. N Engl J Med 2009;361:940-2. Go to original source... Go to PubMed...
    2. Unger EF. Weighing benefits and risks-The FDA's Rewiew of Prasugrel. N Engl J Med 2009;361:942-5. Go to original source... Go to PubMed...
    3. Walentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57. Go to original source... Go to PubMed...
    4. Schömig A. Ticagrelor - is there need for a new player in the atiplatelet-therapy field? N Engl J Med 2009;361:1108-11. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes